Pediatric acute leukemias: focus on clinical trials for treatment
Update: 2025-09-19
Description
Ann Collins, PA, Blood Cancer United, Washington, DC, Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC, Sarah K. Tasian, MD, Children’s Hospital of Philadelphia, Philadelphia, PA
Recorded on September 9, 2025
Ann Collins, PA
Project Leader, Pediatric Acute Leukemia Master Clinical Trial (PedAL)
Blood Cancer United
Washington, DC
Project Leader, Pediatric Acute Leukemia Master Clinical Trial (PedAL)
Blood Cancer United
Washington, DC
Kelly Laschinger, MSN, RN, CPNP, CPHON
Director, Clinical Trial Support Center
Blood Cancer United
Washington, DC
Director, Clinical Trial Support Center
Blood Cancer United
Washington, DC
Sarah K. Tasian, MD
Blood Cancer United PedAL Master Clinical Trial Lead
Associate Professor of Pediatrics, University of Pennsylvania School of Medicine
Chief of Hematologic Malignancies Program, Children’s Hospital of Philadelphia
Philadelphia, PA
Blood Cancer United PedAL Master Clinical Trial Lead
Associate Professor of Pediatrics, University of Pennsylvania School of Medicine
Chief of Hematologic Malignancies Program, Children’s Hospital of Philadelphia
Philadelphia, PA
Join us for our first episode as Blood Cancer United! In this episode, Dr. Sarah Tasian, from Children’s Hospital of Philadelphia, and Ann Collins and Kelly Laschinger, from Blood Cancer United, join us for an in-depth discussion on pediatric acute leukemias. The conversation delves into the latest therapies, treatment challenges, and the complex realities of long-term survivorship. We also explore the groundbreaking Blood Cancer United Pediatric Acute Leukemia Master Clinical Trial (PedAL), its bold vision, global collaboration, and unified approach to data collection. Valuable clinical trial resources and strategies to support patients, families, and healthcare professionals are also shared. Tune in today!
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
